PMC:7696151 / 89317-89607
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2653 | 194-197 | Gene | denotes | DCX | Gene:1641 |
2661 | 16-24 | Species | denotes | patients | Tax:9606 |
2679 | 203-206 | Chemical | denotes | HCQ | MESH:D006886 |
2706 | 30-42 | Disease | denotes | valvulopathy | MESH:D006349 |
2707 | 70-75 | Disease | denotes | fever | MESH:D005334 |
2708 | 271-289 | Disease | denotes | fever endocarditis | MESH:D005334 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T229 | 70-75 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T230 | 271-276 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T231 | 277-289 | Phenotype | denotes | endocarditis | http://purl.obolibrary.org/obo/HP_0100584 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T569 | 0-290 | Sentence | denotes | Furthermore, in patients with valvulopathy and diagnosticated acute Q fever (serologic criteria of a phase II IgG titer ≥ 200 and a phase II IgM titer ≥ 50) the administration as prophylaxis of DCX plus HCQ for at least 12 months resulted to be efficient in preventing Q fever endocarditis. |